Cirrhotic cardiomyopathy: an endocannabinoid connection?

Br J Pharmacol. 2005 Oct;146(3):313-4. doi: 10.1038/sj.bjp.0706332.
No abstract available

MeSH terms

  • Animals
  • Cannabinoid Receptor Modulators / pharmacology*
  • Cardiomyopathies / etiology*
  • Cardiomyopathies / metabolism
  • Cardiomyopathies / physiopathology
  • Endocannabinoids*
  • Humans
  • Liver Cirrhosis, Experimental / complications
  • Liver Cirrhosis, Experimental / metabolism*
  • Liver Cirrhosis, Experimental / physiopathology
  • Myocardial Contraction / drug effects
  • Receptor, Cannabinoid, CB1 / metabolism

Substances

  • Cannabinoid Receptor Modulators
  • Endocannabinoids
  • Receptor, Cannabinoid, CB1